v3.26.1
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of profit or loss and other comprehensive income [abstract]      
Product net sales $ 4,151,316 $ 2,185,883 $ 1,190,783
Other operating income [1] 96,734 66,156 77,811
Total operating income 4,248,050 2,252,039 1,268,594
Cost of sales (450,665) (227,289) (117,835)
Research and development expenses (1,364,132) (983,423) (859,492)
Selling, general and administrative expenses (1,367,057) (1,055,337) (711,905)
Loss from investment in a joint venture (12,390) (7,644) (4,411)
Total operating expenses (3,194,244) (2,273,693) (1,693,643)
Operating profit/(loss) 1,053,806 (21,654) [2] (425,049) [2]
Financial income 163,091 157,509 107,386
Financial expense (4,082) (2,464) (906)
Exchange gains/(losses) 65,792 (48,211) 14,073
Profit/(Loss) for the year before taxes 1,278,607 85,180 (304,496)
Income tax benefit 13,428 747,860 9,443
Profit/(Loss) for the year 1,292,035 833,040 (295,053)
Profit/(Loss) for the year attributable to:      
Owners of the parent $ 1,292,035 $ 833,040 $ (295,053)
Weighted average number of shares used for basic profit/(loss) per share (in shares) 61,295,149 59,855,585 57,169,253
Basic profit/(loss) per share (in USD per share) $ 21.08 $ 13.92 $ (5.16)
Weighted average number of shares used for diluted profit/(loss) per share (in shares) 66,029,215 65,177,815 57,169,253
Diluted profit/(loss) per share (in USD per share) $ 19.57 $ 12.78 $ (5.16)
[1] 1)Comparative figures have been aligned with the presentation adopted in the current period, reflecting the combination of collaboration revenue
and other operating income.
[2] 1)Comparative figures have been aligned to the presentation adopted in the current year.